Because TRAIL-resistance in certain cancer cell lines is attributable to attenuated expression of the TRAIL death receptors DR4 and DR5 or over-expression of the decoy receptors DcR1 and DcR2, we examined the expression of these receptors in various breast cancer cell lines. This evidence concerns the gene TNFRSF10C and breast carcinoma.